Press Releases
Page 7 • 12 itemsAccess critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Anixa Biosciences Lira-cel CAR-T Therapy Shows Positive Survival Data in Ovarian Cancer Phase 1 Trial
Anixa Biosciences announces positive survival data for Lira-cel CAR-T therapy in ovarian cancer Phase 1 trial, with presentation at ISCT 2026 meeting.
Hengrui Pharma Q1 2026 Results: Anti-PD-L1/TGF-βRII Fusion Protein Approved in China
Hengrui Pharma reports Q1 2026 growth with three innovative drug approvals including breakthrough anti-PD-L1/TGF-βRII bi-functional fusion protein in China.
Sonorous Neurovascular Receives FDA 510(k) Clearance for BosCATH™ Neurovascular Catheter
Sonorous Neurovascular gains FDA 510(k) clearance for BosCATH™ catheter, advancing neurovascular intervention capabilities for complex cerebral procedures.
Alphamab Oncology JSKN016 TROP2/HER3 Bispecific ADC Shows Promise for HER2-Negative Breast Cancer at ASCO 2026
Alphamab Oncology presents clinical data for JSKN016, a novel TROP2/HER3 bispecific ADC targeting HER2-negative breast cancer at ASCO 2026 conference.
RFID Technology Market to Reach $15 Billion by 2032, Transforming Pharmaceutical Supply Chain Management
RFID tags market projected to hit $15 billion by 2032, driven by pharmaceutical serialization mandates and IoT integration for enhanced drug tracking.
WuXi Biologics Receives South Korea GMP Certification for Bispecific Antibody Manufacturing
WuXi Biologics secures South Korea MFDS GMP certification for three facilities, enabling commercial manufacturing of bispecific antibody therapeutics.
Kelun-Biotech's Sacituzumab Tirumotecan and Two Other Cancer Drugs Selected for ASCO 2026 Oral Presentations
Kelun-Biotech announces three clinical studies selected for oral presentations at ASCO 2026, including TROP2 ADC sacituzumab tirumotecan results.
NOVI Health's Hybrid Care Model Bridges GLP-1 Drug Efficacy Gap Between Clinical Trials and Real-World Outcomes
NOVI Health introduces hybrid care approach to improve real-world GLP-1 obesity drug outcomes that typically underperform compared to clinical trials.
Duchesnay and PeriPharm Call for Regulatory Reform as Canadian Women Wait 3+ Years for Health Innovations
Duchesnay and PeriPharm publish joint study revealing Canadian women wait over three years to access new health treatments, calling for regulatory updates.
Washington State Life Sciences Industry Leads National Growth for Fifth Consecutive Year, Contributing $24.4B to GDP
Washington's life sciences sector outpaces national growth for 5th year, contributing $24.4B to state GDP with third-largest AI specialist cluster in US.
Suvoda Launches Agentic AI-Powered RTSM System, Reduces Clinical Trial Startup Time by 80%
Suvoda's new agentic RTSM uses AI to cut clinical trial startup timelines by up to 80%, accelerating drug development and patient access to treatments.
Dayspring Pharma's CG2001 Foam Meets Primary Endpoint in Phase II Male Pattern Baldness Trial
Dayspring Pharma announces positive Phase II results for CG2001 foam in treating male pattern baldness, showing significant efficacy in Chinese men.